Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Observational

Turkish Translation of SportsConcussion Assesment Tool 6

NCT06739785 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2024-09-15
Last updated
2025-08-19

Condition(s) studied

Sports InjuryConcussion, MildConcussion, BrainConcussion, SevereConcussion, Intermediate

Investigational drug(s) / intervention(s)

SCAT6-tr

SCAT6-tr: Step 1: Initial Translation At this stage, two independent bilingual translators whose native language is Turkish will translate the content into Turkish. Step 2: Integration of Translations A single translation will be created by comparing the two Turkish versions of SCAT 6. Step 3: Back-translation The Turkish version will be translated into English by 2 bilingual colleagues who are blind to the original version. The Turkish version will be translated into English by 2 bilingual colleagues who are blind to the original version. These two English versions will be compared, differences will be resolved by consensus and a new combined version will be created. If consensus cannot be reached, a third person will be asked for help. Step 4: Expert Evaluation

Study summary

Concussions, a significant type of sports injury caused by head, face, or neck trauma, are common in contact sports and require serious attention due to potential fatal consequences of mismanagement. The Sport Concussion Assessment Tool (SCAT), developed by the Concussion in Sport Group (CISG) and updated in 2023, provides a standardized approach to assess head injuries and manage athletes' return-to-sport process. While SCAT has been adapted into various languages, no Turkish version exists. This study aims to translate and culturally adapt SCAT 6 into Turkish, contributing to the accurate evaluation and management of concussion injuries among Turkish-speaking athletes.

Eligibility

Sex
ALL
Min age
13 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: To be 13 years old * Talking in Turkish * Being a Professional Athlete Exclusion Criteria: * Athletes who experience any injury during the test, retest process will be excluded from the study.

Primary outcome measure(s)

  • Lawshe Analysis — Before the create last verison of SCAT6-tr .It is planned to take 1 month.
    The appropriateness of the assessment tool will be determined by analysing the expert opinion forms reported by the experts.

Trial sites (1)

FacilityCityRegionStatus
Ordu University Ordu Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06739785 on ClinicalTrials.gov ↗ ← All trials in Turkey